IP Library Granted Patent US 9,938,514
Granted Patent B2
US 9,938,514 · App. 15/155,302 · Granted Apr 10, 2018

Methods of intracellular conversion of single-chain proteins into their di-chain form

Inventors: Sanjiv Ghanshani (Irvine, CA); Linh Q. Le (Tustin, CA); Yi Liu (Irvine, CA); Lance E. Steward (Irvine, CA)
Assignee: Allergan, Inc.
C12N9/52C07K14/33C12N9/506C12N15/70C12P21/00C12P21/06C07K2319/50C12N2799/026
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,938,514
App. No.
15/155,302
Granted
Apr 10, 2018
Kind
B2
Abstract

The present specification discloses expression constructs comprising single-chain proteins comprising a di-chain loop region comprising an exogenous protease cleavage site and a protease that can cleave the exogenous protease cleavage site located within the di-chain loop, cell compositions comprising such expression construct, and intracellular methods of converting the single-chain protein into its di-chain form.

Claims (6)

1. A dual expression construct comprising: i) an open reading frame encoding a single-chain Clostridial toxin, the single-chain Clostridial toxin comprising an enzymatic domain, a translocation domain, a binding domain, and a di-chain loop region comprising a TEV protease cleavage site; and ii) an open reading frame encoding a TEV protease.

2. A dual expression construct comprising: i) an open reading frame encoding a single-chain protein, the single-chain protein comprising an enzymatic domain, a translocation domain, an integrated TEV protease cleavage site-opioid binding domain; and

ii) an open reading frame encoding a TEV protease.

3. A dual expression construct comprising: i) an open reading frame encoding a single-chain protein, the single-chain protein comprising an enzymatic domain, a translocation domain, a non-Clostridial toxin binding domain and a di-chain loop region comprising a TEV protease cleavage site; and ii) an open reading frame encoding a TEV protease.

4. The dual expression of claim 1 , wherein the open reading frame comprises SEQ ID NO: 87.

5. The dual expression of claim 1 , wherein the single-chain Clostridial toxin comprises SEQ ID NO: 88.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 16, 2016
From: GHANSHANI, SANJIV; LE, LINH Q.; LIU, YI; STEWARD, LANCE E.
To: ALLERGAN, INC.
Reel/Frame 038602/0195 →
Continuity (3)
Division 14038328 · Sep 26, 2013
Continuation 13575222
Related Publication 20160319265A1 · Nov 3, 2016